David M. Paton

3.0k total citations
145 papers, 2.1k citations indexed

About

David M. Paton is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David M. Paton has authored 145 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 35 papers in Physiology and 34 papers in Cellular and Molecular Neuroscience. Recurrent topics in David M. Paton's work include Ion channel regulation and function (30 papers), Receptor Mechanisms and Signaling (16 papers) and Pain Mechanisms and Treatments (14 papers). David M. Paton is often cited by papers focused on Ion channel regulation and function (30 papers), Receptor Mechanisms and Signaling (16 papers) and Pain Mechanisms and Treatments (14 papers). David M. Paton collaborates with scholars based in Canada, New Zealand and United States. David M. Paton's co-authors include Dianne Webster, E. E. Daniel, Anthony Johns, A. Johns, Alexander S. Clanachan, Grahame S. Taylor, Milan J. Muller, Thomas D. White, Sheila A Doggrell and Joan Willemot and has published in prestigious journals such as Nature, The Lancet and Pharmacological Reviews.

In The Last Decade

David M. Paton

140 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Paton Canada 24 961 694 359 300 177 145 2.1k
Jack N. Wells United States 29 1.4k 1.4× 421 0.6× 539 1.5× 501 1.7× 291 1.6× 79 2.3k
Richard A. Bjur United States 22 805 0.8× 525 0.8× 463 1.3× 576 1.9× 173 1.0× 40 1.8k
M A Zar United Kingdom 19 806 0.8× 865 1.2× 525 1.5× 106 0.4× 86 0.5× 43 2.0k
Kishio Furuya Japan 29 1.0k 1.1× 474 0.7× 297 0.8× 319 1.1× 114 0.6× 85 2.3k
D. H. Jenkinson United Kingdom 27 1.8k 1.9× 1.3k 1.9× 455 1.3× 104 0.3× 407 2.3× 46 2.7k
Arsélio P. Carvalho Portugal 35 1.7k 1.8× 1.4k 2.0× 412 1.1× 177 0.6× 173 1.0× 88 3.2k
Fumiaki Hata Japan 29 1.3k 1.3× 903 1.3× 655 1.8× 102 0.3× 150 0.8× 139 2.5k
Yuji Kiuchi Japan 32 1.1k 1.1× 647 0.9× 896 2.5× 167 0.6× 133 0.8× 175 3.2k
Barbara Robertson United States 23 783 0.8× 291 0.4× 271 0.8× 293 1.0× 91 0.5× 53 1.8k
Hirotoshi Shimizu Japan 25 1.1k 1.2× 826 1.2× 289 0.8× 421 1.4× 37 0.2× 59 2.2k

Countries citing papers authored by David M. Paton

Since Specialization
Citations

This map shows the geographic impact of David M. Paton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Paton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Paton more than expected).

Fields of papers citing papers by David M. Paton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Paton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Paton. The network helps show where David M. Paton may publish in the future.

Co-authorship network of co-authors of David M. Paton

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Paton. A scholar is included among the top collaborators of David M. Paton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Paton. David M. Paton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paton, David M.. (2022). Loteprednol etabonate: a formulation for short-term use in inflammatory flares in dry eye disease. Drugs of today. 58(2). 77–84. 10 indexed citations
2.
Paton, David M.. (2022). Estetrol and drospirenone: a novel oral contraceptive. Drugs of today. 58(1). 1–8. 2 indexed citations
3.
Paton, David M.. (2021). Vibegron: a beta3-adrenergic agonist for the treatment ofoveractive bladder. Drugs of today. 57(8). 507–507. 2 indexed citations
4.
Paton, David M.. (2020). Drospirenone: a novel progestogen used as an oral contraceptivewithout an estrogen component. Drugs of today. 56(5). 321–321. 3 indexed citations
5.
Paton, David M.. (2020). Istradefylline: adenosine A2A receptor antagonist to reduce "OFF"time in Parkinson's disease. Drugs of today. 56(2). 125–125. 13 indexed citations
8.
Paton, David M.. (2016). Lifitegrast: First LFA-1/ICAM-1 antagonist for treatment of dry eyedisease. Drugs of today. 52(9). 485–485. 12 indexed citations
9.
Paton, David M.. (2014). Romosozumab. Humanized anti-sclerostin monoclonal antibody, Treatment of osteoporosis. Drugs of the Future. 39(8). 553–553. 2 indexed citations
10.
Elsby, Robert, John Ashby, John P. Sumpter, et al.. (2000). Obstacles to the prediction of estrogenicity from chemical structure: assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor. Biochemical Pharmacology. 60(10). 1519–1530. 34 indexed citations
11.
Stone, Trevor W. & David M. Paton. (1989). Possible subtypes of ATP receptor producing contraction of rat vas deferens, revealed by cross-desensitisation. General Pharmacology The Vascular System. 20(1). 61–64. 18 indexed citations
12.
Webster, Dianne, et al.. (1986). Relationship of metabolism of 2?-, 3?- and 5?-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 333(2). 163–167. 2 indexed citations
13.
Webster, Dianne, et al.. (1985). Measurement of adenosine metabolites and metabolism in isolated tissue preparations. Journal of Pharmacological Methods. 13(4). 339–350. 11 indexed citations
14.
Widdicombe, J. H., A. Johns, & David M. Paton. (1977). Responses of the monkey oviduct to transmural electrical stimulation and to drugs. Reproduction. 50(1). 141–144. 4 indexed citations
15.
Johns, A. & David M. Paton. (1975). Effect of Cocaine and Other Drugs on Sensitivity of the Estrogen-dominated Isthmus of Rabbit Oviduct to Noradrenaline. Canadian Journal of Physiology and Pharmacology. 53(6). 1172–1177. 4 indexed citations
16.
Paton, David M.. (1973). Evidence for carrier-mediated efflux of noradrenaline from the axoplasm of adrenergic nerves in rabbit atria. Journal of Pharmacy and Pharmacology. 25(3). 265–267. 27 indexed citations
17.
Taylor, Grahame S., David M. Paton, & E. E. Daniel. (1970). Characteristics of Electrogenic Sodium Pumping in Rat Myometrium. The Journal of General Physiology. 56(3). 360–375. 73 indexed citations
18.
Taylor, Grahame S., David M. Paton, & E. E. Daniel. (1969). Evidence for an electrogenic sodium pump in smooth muscle. Life Sciences. 8(13). 769–773. 24 indexed citations
19.
Paton, David M.. (1968). Effects of metabolic inhibitors on contraction of rabbit detrusor muscle. British Journal of Pharmacology. 34(3). 493–498. 7 indexed citations
20.
Paton, David M.. (1964). BETA-RECEPTOR BLOCKADE IN THE DIAGNOSIS OF PHÆOCHROMOCYTOMA. The Lancet. 284(7369). 1125–1125. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026